Skip to content

Clinical trials

Alzheimer Disease trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Alzheimer Disease Country / region: South Korea Clear all

168 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20041
20053
20062
20076
200811
20096
20106
20115
20127
20138
201415
20154
201612
20178
20185
20196
20208
20216
202212
20233
202410
202517
20266

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed76
Terminated32
Recruiting25
Unknown status23
Active, not recruiting9
Not yet recruiting2
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hoffmann-La Roche14
GlaxoSmithKline10
Seoul National University Hospital10
Samsung Medical Center9
Eisai Korea Inc.7
Eli Lilly and Company6
Pfizer6
Bristol-Myers Squibb4
Novartis Pharmaceuticals4
AstraZeneca3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Alzheimer Disease168
Dementia37
Cognitive Dysfunction28
Brain Diseases15
Neurodegenerative Diseases14
Nervous System Diseases12
Central Nervous System Diseases11
Mental Disorders10
Tauopathies10
Neurocognitive Disorders8

Trials

Showing 26 to 50 of 168. Each trial links to its page on Pharma Observatory.

68 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.